세계의 바이오의약품 물류 시장 보고서(2025년)
Bio-Pharmaceutical Logistics Global Market Report 2025
상품코드 : 1784209
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,430,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,294,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,159,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

바이오의약품 물류 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년에는 CAGR 10.7%를 나타내 2,356억 9,000만 달러로 성장할 전망입니다. 예측기간의 성장은 유전자·세포치료 시장 성장, 지속가능 물류의 실천, 희소질병용 의약품 개발 증가, 자율주행차의 채용, 생물제제와 바이오시밀러 수요, 정밀의료 물류에 기인한다고 생각됩니다. 예측 기간의 주요 동향으로는 물류 기술 통합, 공급망 디지털화, 위험 완화 및 예기치 않은 상황 대응, 전략적 파트너십과 제휴, 환자 중심 유통 모델 등이 있습니다.

향후 5년간의 성장률 10.7%라고 하는 예측은 전회의 예측으로부터 0.2%의 미감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 온도 관리 용기 및 콜드체인 센서에 대한 관세는 물류 비용을 증가시키고 온도에 민감한 생물학적 제제의 무결성을 위태롭게 할 수 있습니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향이 보다 광범위하게 이어질 수 있습니다.

생물제제의 채용 확대가 향후 바이오의약품 물류 시장을 견인할 것으로 예측됩니다. 생물 제제는 생물에서 생산되거나 생물의 성분을 포함하는 강력한 의약품입니다. 생물 제제는 섬세하기 때문에 용기 및 포장과 상호 작용할 수 있으며 저온 또는 극저온에서 보관해야합니다. 바이오의약품 물류에는 혈장 및 온도에 민감한 제품과 같은 바이오의약품을 처리하는 서비스가 포함되어 있으며 생물 제제, 의약품 및 백신과 같은 구명 건강 관리 제품에 대한 액세스를 보장합니다. 예를 들어, 2024년 1월 미국 제약 임상 연구 회사인 IQV는 전 세계 의약품 사용량이 지난 5년간 14% 증가했으며, 2028년까지 추가 12% 증가할 것으로 예상되며 연간 사용량은 정의된 1일 용량으로 3조 8,000억 회에 달한다고 보고했습니다. 따라서 생물 제제의 사용 증가는 바이오의약품 물류 시장 성장을 이끌고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

제36장 부록

KTH
영문 목차

영문목차

Biopharmaceuticals are medicinal drugs developed through biotechnology, and their logistics involve the intricate management of transportation, warehousing, packaging, and distribution, including inventory supervision. This specialized field encompasses the handling of delicate substances such as plasma and temperature-sensitive products.

Primary segments within biopharmaceutical logistics consist of cold chain logistics and non-cold chain logistics. Cold chain logistics incorporates technologies and procedures enabling the secure transport of temperature-sensitive items throughout the supply chain. Services provided encompass transportation, warehousing, distribution, and value-added services. These are accessible through specialty stores, hypermarkets, and departmental outlets and cater to various sectors including ground, sea, and air shipping. End-users encompass pharmaceuticals, biopharmaceuticals, pharmacies, hospitals, clinics, supermarkets, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a considerable impact on the transport services sector by increasing the costs of vehicles, spare parts, and fuel-critical inputs frequently imported from tariff-affected regions. Freight operators, logistics companies, and public transportation providers are experiencing margin pressures as elevated equipment and maintenance expenses coincide with limited flexibility to pass these costs on to customers due to intense market competition. This climate of uncertainty has also led to delays in fleet upgrades and the adoption of greener, more energy-efficient vehicles, hindering progress toward sustainability objectives. In response, transport firms are enhancing route optimization, investing in fuel-efficient technologies, renegotiating supplier agreements, and adopting collaborative logistics strategies to share resources and cushion the financial impact of rising tariffs.

The biopharmaceutical logistics market research report is one of a series of new reports from The Business Research Company that provides bio-pharmaceutical logistics market statistics, including bio-pharmaceutical logistics industry global market size, regional shares, competitors with a bio-pharmaceutical logistics market share, detailed bio-pharmaceutical logistics market segments, market trends and opportunities, and any further data you may need to thrive in the bio-pharmaceutical logistics industry. This bio-pharmaceutical logistics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The bio-pharmaceutical logistics market size has grown strongly in recent years. It will grow from $143.19 billion in 2024 to $156.9 billion in 2025 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to rise in clinical trials, globalization of pharmaceutical supply chains, increase in personalized medicine, temperature-sensitive clinical materials, focus on patient-centric logistics, pharmaceutical serialization initiatives.

The bio-pharmaceutical logistics market size is expected to see rapid growth in the next few years. It will grow to $235.69 billion in 2029 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to gene and cell therapies market growth, sustainable logistics practices, rise in orphan drug development, adoption of autonomous vehicles, demand for biologics and biosimilars, precision medicine logistics. Major trends in the forecast period include technology integration in logistics, digitalization of supply chains, risk mitigation and contingency planning, strategic partnerships and collaborations, patient-centric distribution models.

The forecast of 10.7% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Duties on temperature-controlled containers and cold chain sensors could increase logistics costs, jeopardizing the integrity of temperature-sensitive biologics. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing adoption of biologics is expected to drive the bio-pharmaceutical logistics market in the future. Biologics are powerful medications produced from living organisms or containing components of living organisms. Due to their sensitivity, biological drugs may interact with containers or packaging, necessitating cold or even cryogenic storage. Biopharmaceutical logistics involves services for handling biopharmaceuticals such as plasma and temperature-sensitive products, ensuring access to life-saving healthcare products, including biologics, medicines, and vaccines. For example, in January 2024, IQV, a US-based pharma clinical research company, reported that global medicine usage grew by 14% over the past five years, with an anticipated additional 12% increase through 2028, raising annual use to 3.8 trillion defined daily doses. Thus, the increasing use of biologics is driving the growth of the bio-pharmaceutical logistics market.

The growing demand for personalized medicine is expected to be a key driver for the bio-pharmaceutical logistics market. Personalized medicine involves tailoring medical decisions, practices, interventions, and drug therapies to individual patients. Bio-pharmaceutical logistics services that cater to the unique requirements of personalized medicine contribute to enhanced effectiveness, safety, and accessibility of individualized treatments. These services also offer customized distribution models, ultimately benefiting patients and advancing the field of precision medicine. As of October 2022, there were over 75,000 genetic testing products and 300 personalized medicines, as reported by STAT, a US-based health-oriented news company. The rising demand for personalized medicine is, therefore, a significant factor propelling the growth of the bio-pharmaceutical logistics market.

Technological advancement is a prominent trend gaining traction in the bio-pharmaceutical logistics market. Major companies in the market are embracing innovative technologies to maintain their competitive edge. For instance, in September 2022, CubeWorks, a US-based company specializing in breakthrough smart sensing solutions, introduced CubiSens XT1. This next-generation visibility solution for cold chain logistics, equipped with the world's smallest temperature tracker and ultra-small IoT sensing technology, monitors biopharma products throughout their entire lifecycle. The CubiSens XT1 ensures temperature compliance and quality assurance, addressing challenges in fragmented temperature monitoring, data aggregation, and incomplete tracking across the supply chain. Powered by CubeWorks' patented ultra-low power system-on-chip solution, the CubiSens XT1 offers scalability and cost-effectiveness, marking a significant technological advancement in the bio-pharmaceutical logistics market.

Prominent companies in the bio-pharmaceutical logistics market are directing their focus towards innovating advanced logistics solutions, particularly in the realm of ultra-low temperature-controlled logistics, to enhance their market operations. Ultra-low temperature-controlled logistics involves the storage, preservation, and transportation of goods requiring maintenance at extremely low temperatures. Notably, Nippon Express, a Japan-based logistics company, has introduced an ultra-low temperature-controlled logistics service specifically tailored for the pharmaceutical industry. This service is designed to handle goods demanding ultra-low temperatures, ranging from -20°C to -85°C. With a strategic emphasis on the pharmaceutical sector, Nippon Express is actively developing quality control systems and enhancing its business infrastructure in alignment with Good Distribution Practices (GDP) established for pharmaceuticals. The service covers a wide spectrum of pharmaceutical commodities, including raw materials, intermediates, active pharmaceutical ingredients, and finished products.

In August 2022, CRYOPDP, a France-based company specializing in innovative temperature-controlled logistics solutions for clinical research, acquired Polar Express for an undisclosed amount. This strategic acquisition positions CRYOPDP to expand its coverage in Europe and offer solutions to both global and local customers in Spain. Polar Express, based in Spain, is recognized for providing worldwide temperature-controlled shipping services for biopharmaceutical and biological commodities. The acquisition underscores the industry's commitment to strengthening and extending temperature-controlled logistics capabilities, reflecting the importance of advanced solutions in the bio-pharmaceutical logistics market.

Major companies operating in the bio-pharmaceutical logistics market include Kuehne + Nagel International AG, FedEx Corporation, SF Express Co. Ltd., Dalsey Hillblom and Lynn, Kerry Logistics Network Limited, AmerisourceBergen Corporation, United Parcel Service of America Inc., DB Schenker, Agility Public Warehousing Company K.S.C.P., C.H. Robinson Worldwide Inc., Ceva Logistics, Nippon Express, GEODIS S.A., Air Canada Cargo, World Courier Inc., QuickSTAT Global Life Science Logistics Inc., Marken, Biocair, Almac Group, PCI Pharma Services Holdings LLC, Cryoport Inc., MNX Global Logistics LLC., Movianto, Clinical Trial Logistics, Thermo Fisher Scientific, World Courier Management Inc., Cardinal Health Inc., Parexel International Corporation, Selvita S.A.

North America was the largest region in the bio-pharmaceutical logistics market share in 2024. The regions covered in the bio-pharmaceutical logistics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the bio-pharmaceutical logistics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biopharmaceutical logistics market includes revenues earned by entities by providing road shipping and rail shipping biopharmaceutical logistics services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bio-Pharmaceutical Logistics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bio-pharmaceutical logistics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for bio-pharmaceutical logistics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The bio-pharmaceutical logistics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Bio-Pharmaceutical Logistics Market Characteristics

3. Bio-Pharmaceutical Logistics Market Trends And Strategies

4. Bio-Pharmaceutical Logistics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Bio-Pharmaceutical Logistics Growth Analysis And Strategic Analysis Framework

6. Bio-Pharmaceutical Logistics Market Segmentation

7. Bio-Pharmaceutical Logistics Market Regional And Country Analysis

8. Asia-Pacific Bio-Pharmaceutical Logistics Market

9. China Bio-Pharmaceutical Logistics Market

10. India Bio-Pharmaceutical Logistics Market

11. Japan Bio-Pharmaceutical Logistics Market

12. Australia Bio-Pharmaceutical Logistics Market

13. Indonesia Bio-Pharmaceutical Logistics Market

14. South Korea Bio-Pharmaceutical Logistics Market

15. Western Europe Bio-Pharmaceutical Logistics Market

16. UK Bio-Pharmaceutical Logistics Market

17. Germany Bio-Pharmaceutical Logistics Market

18. France Bio-Pharmaceutical Logistics Market

19. Italy Bio-Pharmaceutical Logistics Market

20. Spain Bio-Pharmaceutical Logistics Market

21. Eastern Europe Bio-Pharmaceutical Logistics Market

22. Russia Bio-Pharmaceutical Logistics Market

23. North America Bio-Pharmaceutical Logistics Market

24. USA Bio-Pharmaceutical Logistics Market

25. Canada Bio-Pharmaceutical Logistics Market

26. South America Bio-Pharmaceutical Logistics Market

27. Brazil Bio-Pharmaceutical Logistics Market

28. Middle East Bio-Pharmaceutical Logistics Market

29. Africa Bio-Pharmaceutical Logistics Market

30. Bio-Pharmaceutical Logistics Market Competitive Landscape And Company Profiles

31. Bio-Pharmaceutical Logistics Market Other Major And Innovative Companies

32. Global Bio-Pharmaceutical Logistics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Bio-Pharmaceutical Logistics Market

34. Recent Developments In The Bio-Pharmaceutical Logistics Market

35. Bio-Pharmaceutical Logistics Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기